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The purpose of present work was to formulate fluconazole 
loaded microsponge-based topical delivery system for modified 
release. Microsponges with varied drug–polymer ratios were 
prepared by emulsion solvent diffusion technique using ethyl 
cellulose as release retard material. Prepared microsponges were 
studied for particle size and physical characterization. Scanning 
Electron Microscopy (SEM) images showed the microsponges 
porous and spherical in shape. The microsponges were then 
incorporated in carbopol gel and evaluated for pH, viscosity, 
spreadability, drug content, in vitro release. The In vitro drug 
release showed that microsponges with 1:1.5 drug–polymer 
ratios (F3) were more efficient to give sustained release of 
74.2% at the end of 8h. All the microsponge gel formulations 
(i.e.F1-F10) showed better results like pH between 6.5-7.0, 
viscosity between 25,030-47,390 cps, spreadability 2-4cm/s and 
drug content of 76.20±0.02% to 96.41±0.01%.  Hence, the 
fabricated microsponge based formulation of fluconazole would 
be anticipation and promising substitute to conventional therapy 
of skin infections. 
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INTRODUCTION 
Fluconazole is a synthetic antifungal 
agent belonging to the group of triazole. It is 
one of the commonly used antifungal agents 
for most kinds of fungal infections including 
superficial and invasive fungal infections 
(Vinod et al., 2012). Regrettably fluconazole oral 
administration has limitations such as nausea, 
vomiting, bloating and abdominal discomfort. 
Alongside most of the time the parenteral 
administration of fluconazole led to skin rashes 
and itching (Doaa et al., 2012). For these 
reasons, now a day’s advance localized and 
transdermal delivery has gained a lot of 
importance (Niethard et al., 2005; Kulkarni et 
al., 2011). The conventional gel formulation of 
fluconazole causes cutaneous irritation and 
prolonged use led to dermal hypersensitivity.  
So, a novel system necessitates which will 
increase the presence of active agents either on 
skin surface or within epidermis, concurrently 
reducing hasty transdermal penetration. Many 
researchers have attempted to develop novel 
transdermal formulations of fluconazole. 
Accordingly, the goal of our research is to 
formulate and evaluate fluconazole 
microsponge loaded carbopol gel for safe, 
effective and stable gel and evaluate the in-vitro 
sustained release performance. Microsponge-
based delivery systems (MDS) give assurance of 
drug localization on skin surface and within 
epidermis without entering in systemic 
circulation in greater extent; thereby reducing 
systemic and local cutaneous adversities. They 
also offer an advantage of programmable 
release and are biologically safe. Additionally, 
this technology presents quite a lot of benefits 
via drug entrapment by means of better 
formulation flexibility, abridged side effects, 
improved elegance and superior stability 
(D’souza and More, 2008; Vyas et al., 2010; 
Vyas and Khar, 2002; Won, 1987).  
 
MATERIALS AND METHODS 
Fluconazole was obtained as a gift 
sample from RMS Research labs Pvt Ltd 
Hyderabad, India. Ethyl cellulose was gifted by 
Yeluri formulations, Hyderabad, India.  
Polyvinyl alcohol, triethyl citrate and ethyl 
acetate were purchased from Emerck (India) 
Ltd., Mumbai. All other chemicals and solvents 
used are of analytical grade. 
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All the microsponge formulations were 
prepared using emulsion solvent diffusion 
method (Orlu et al., 2006). In this experiment 
required an amount of ethyl cellulose and 
triethyl citrate were dissolved in ethyl acetate 
(EA) further fluconazole was added and stirred 
well.  EA was noticed as an effective solvent 
for dissolving both the drug and the 
polymer. The EA solution was gradually added 
in 25mL of an aqueous solution of poly vinyl 
alcohol (PVA) at room temperature with 
continuous stirring. Then the final mixture was 
filtered through filter paper with a pore size of 
0.45µm to separate formed microsponges and 
dried at room temperature (Table I). 
 
Characterization of microsponge 
formulations  
Fourier Transform Infrared (FT-IR) 
Studies 
IR spectra of the pure drug, other 
excipients and formulations were obtained and 
compared. In the present study, potassium 
bromide (KBr) pellet method was employed. 
The samples were thoroughly mixed with                 
dry powder of potassium bromide and scanned 
from 4000-400cm-1 by FT-IR spectrophoto-
meter (Model number 02437 Shimadzu, India) 
 
Scanning electron microscopy  
The morphology and appearance of the 
microsponges were studied using SEM (SEM-
JEOL Instrument, JSM- 6360, Japan) operating 
at 15kV. The samples were dusted onto double-
sided tape on a metal stub and coated with 
gold/palladium alloy under vacuum. The 
obtained photograph was recorded at x400 
magnification (Nokhodchi et al., 2007). 
 
 
Production yield actual FLZ content, and 
entrapment efficiency (EE %) 
The production yield (PY) was 
determined by following formula (Kilicarslan 
and Baykara, 2003; Mine et al., 2006.) accurately 
calculating the initial weight of the raw 
materials and the weight of the obtained 
microsponge particles. Samples of drug loaded 
microsponges (20mg) were dissolved in 10mL 
phosphate buffer pH 5.5 under sonication for 
20min at 25°C. The samples were filtered using 
0.45µm membrane filter and analyzed for FLZ 
content spectrophotometrically using Shimadzu 
UV-1650 UV–VIS double beam spectrophoto-
meter (Shimadzu, Japan) at 260nm. The actual 
drug content and EE were calculated as given 
below. 
The actual drug content (%) = 
Mact 
 x 100 
Mms 
The EE (%) was calculated according to the 
following equation:  
Entrapment efficiency  = 
Mact 
 x 100 
Mthe 
 
Where Mact is the actual FLZ content in 
the weighed quantity of the microsponge, Mms 
is the weighed quantity of powder of micro-
sponges, and Mthe is the theoretical amount of 
FLZ in microsponge calculated from the quantity 
added during preparation. All the experiments 
were performed in triplicate and the mean of 
the values was reported. 
 
Particle size analysis 
Particle size analysis of prepared 
microsponges was carried out using particle 
size analyzer (Malvern Mastersizer Hydro 2000, 
Ver.5.54 Malvern,  UK)  which  allows  sample  
Table I. Composition of fluconazole microsponges 
S.No Ingredients Formulation batches of fluconazole microsponge 
  F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
1 D/P ratio 1:0.5 1:1 1:1.5 1:2 1:2.5 1:3 1:1.5 1:1.5 1:1.5 1:1.5 
2 Ethyl acetate (mL) 10 10 10 10 10 10 10 10 10 10 
3 Triethyl citrate (mL) 1 1 1 1 1 1 1 1 1 1 
4 PVA (%w/v) 0.75 0.75 0.75 0.75 0.75 0.75 0.45 0.6 0.9 1 
5 Water (mL) 90 90 90 90 90 90 90 90 90 90 
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measurement in the range of 0.020–2000 mm 
and the particle refractive index was set to 
1.520.  Microsponges were dispersed in double 
distilled water before running the sample in the 
instrument to ensure that light scattering signal 
(as indicated by particles count per second) is 
within the sensitivity range of the instrument. 
 
Preparation of fluconazole microsponge 
gel 
For preparing fluconazole microsponge 
gel, 0.5g of carbopol 940 was uniformly 
dispersed in beakers containing sufficient 
quantity of water and was allowed to hydrate 
overnight. Then it was mixed with 5g of 
glycerin with methyl paraben to form a paste. 
Next, 95mL of water was added slowly to paste 
under constant stirring, followed by drop wise 
triethanolamine addition to adjusting pH to 
6.5–7.5. A calculated amount of FLZ 
microsponge was incorporated which makes 
the final concentration of FLZ in the gel is 1% 
w/w. 
 
Evaluation of fluconazole microsponge 
loaded carbopol gel 
Following evaluation studies of 
fluconazole microsponge loaded carbopol gel 
was done by already established methods. 
 
Visual inspection 
The organoleptic properties such as 
color, texture, consistency, homogeneity and 
physical appearance of gels containing 




The pH of the prepared fluconazole 
loaded microsponge gel was measured using 
pH – meter by putting the tip of the electrode 
into the gel and after 2min the result was 
recorded (Farhan et al., 2008). 
 
Spreadability  
A sample of 0.1g of the gel was pressed 
between 2 slides with 500g weights and left for 
about 5min where no more spreading was 
expected. Diameters of spread circles were 
measured in cm and were taken as comparative 
values for spreadability (diameter of the spread 
circle-initial diameter (El-Houssieny and 
Hamouda, 2010). 
S  = 
ML  
 x 100 
T 
Where M = weight (in g) attached to the upper 
slide, L = length (in cm) of glass slides, and 
T = time (in s) taken to separate the slides. 
Wooden block-glass slide apparatus was 
used and by applying weight about 20g, time 
for complete separation of upper slide 




Rheology includes the measurement of 
viscosity, which indicates the resistance of a 
fluid to flow. The viscosity of gel was 
determined by using Myr Rotational (cup and 
bop) digital viscometer with spindle no. R7 
with optimum speeds 2.5, 3, 4, 5, 6, 10, 12 rpm 
at room temperature (Roaa et al., 2014).  
 
In vitro drug release 
The in vitro release of gel formulations 
was studied using franz diffusion cells. The 
cellophane membrane (0.45μm) previously 
soaked overnight in dissolution medium was 
mounted onto franz diffusion cell with 15mL 
receptor compartment and effective diffusion 
area 2.84 cF2. PBS (pH 7.4) was used as 
receptor medium, and the system was 
thermostatically set to 37±1°C under constant 
stirring. 2g of microsponge from each batch 
were conducted for the diffusion study. 
Aliquots of 1mL volume were withdrawn at 
specific time intervals by maintaining sink 
condition. Withdrawn aliquots were then 
diluted using receptor medium and analyzed by 
a UV spectrophotometer (Shimadzu 1601, 
Kyoto, Japan) at 260nm against PBS pH 7.4. 
To reveal drug release mechanism and to 
contrast, release profiles disparities among 
formulations, data obtained from timely drug 
release were used. Further, release data were 
analyzed by means of diverse mathematical 
models to know release kinetics (Zaki et al., 
2011). 
 
Drug release kinetics 
To analyze the mechanism of 
fluconazole release from the formulations, the 
in vitro release data were fitted into various 
release kinetic models. The models used are: 
zero  order,  first  order,  Higuchi   model  and 
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Korsmeyer - Peppas (Costa and Lobo, 2001). 
The model with the highest correlation 




Optimized gel formulation was subjected 
to stability testing as per ICH. The gel was 
filled in clean collapsible aluminum tubes and 
kept at 40°C and 75% RH in a humidity 
chamber. The gel was assessed for change in 
appearance, pH or in vitro release profile at an 
interval of 0, 15, 30, 60 and 90 days. 
 
RESULTS AND DISCUSSIONS 
Fourier Transform Infrared (FT-IR) 
The IR spectra of pure fluconazole and 
formulation are shown in figure and table.  The 
peak at 3120cm-1 indicates O-H stretching, 
3012cm-1 for the C-H stretching, 1620cm-1               
for the aromatic C=C stretching, 1597cm-1              
for the N-H bending, 1354cm-1 for the                 
C-H bending. These are the major spectral 
peaks of the drug. All these peaks were present 
in the formulations and thus this confirms that 
the drug did not have any interaction with the 








Figure 2. a. SEM of fluconazole loaded microsponges under ×400. b Image of pores on 
microsponge surface under ×400 
 
Topical Antifungal Gels by Microsponge 
162   Volume 28 Issue 3 (2017) 
   
Table II. Actual drug content, encapsulation efficiency and production yield 
 









(%) ± SD 
Production 
yield (%) ± SD 
F1 1:0.5 75 72.58±0.01 85.56±0.01 32.12±0.21 
F2 1:1 60 58.02±0.02 85.12±0.02 34.60±0.20 
F3 1:1.5 53 50.46±0.01 84.10±0.03 38.40±0.39 
F4 1:2 41 37.23±0.14 83.42±0.01 40.00±0.01 
F5 1:2.5 36 32.16±0.02 82.10±0.03 45.13±0.04 
F6 1:3 28 30.16±0.02 80.10±0.03 52.24±0.02 
F7 1:1.5 53 49.35±0.01 89.37±0.21 77.61±0.02 
F8 1:1.5 53 49.27±0.02 82.62±0.01 37.52±0.11 
F9 1:1.5 53 49.83±0.01 46.12±0.02 23.31±0.17 
F10 1:1.5 53 51.13±0.02 49.10±0.01 21.64±0.15 
 
Table III. Kinetic data analysis of optimized microsponge formulation 
 







Log Cum % 
Remaining 








1 27.5 1 1.860338007 0 1.439332694 1 27.5 
2 31.9 2 1.833147112 0.301029996 1.503790683 1.414213562 31.9 
3 36.3 3 1.804139432 0.477121255 1.559906625 1.732050808 36.3 
4 42.7 4 1.758154622 0.602059991 1.630427875 2 42.7 
5 48.6 5 1.710963119 0.698970004 1.686636269 2.236067977 48.6 
6 57.3 6 1.630427875 0.77815125 1.758154622 2.449489743 57.3 
7 65.8 7 1.534026106 0.84509804 1.81822894 2.645751311 65.8 
8 74.2 8 1.411619706 0.903089987 1.870403905 2.828427125 74.2 
 






(%) ± SD 
Encapsulation 
efficiency (%) ± SD 
% CDR ± SD 
F3 0.75 38.40±0.39 84.10±0.03 74.2±0.46 
F7 0.45 77.61±0.02 89.37±0.21 73.7±0.29 
F8 0.60 37.52±0.11 82.62±0.01 71.4±0.23 
F9 0.90 23.31±0.17 46.12±0.02 68.1±0.27 
F10 1.00 21.64±0.15 49.10±0.01 66.2±0.32 
 






yield (%) ± SD 
Drug content 
(%) ± SD 
Encapsulation 
efficiency (%) ± SD 
% 
CDR ± SD 
F1 1:0.5 32.12±0.21 72.58±0.01 85.56±0.01 94.1±0.01 
F2 1:1 34.60±0.20 58.02±0.02 85.12±0.02 85.1±0.01 
F3 1:1.5 38.40±0.39 50.46±0.01 84.10±0.03 74.2±0.02 
F4 1:2 40.00±0.01 37.23±0.14 83.42±0.01 65.1±0.01 
F5 1:2.5 45.13±0.04 32.16±0.02 82.10±0.03 52.8±0.03 
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Scanning electron microscopy  
The morphology of the prepared 
microsponges was studied by SEM analysis. 
The shape and surface characteristics of the 
microsponges are shown in (Figure 2) the 
microsponges were finely spherical and 
uniform in shape, highly porous in nature. The 
pores were created by diffusion of solvent from 
the surface of microsponges. The captured SEM 
images of microsponges are shown in (Figure 2).  
 
Production yield actual FLZ content, and 
entrapment efficiency (EE %) 
The effect of D/P ratio of production 
yield, encapsulation efficiency and drug 
content (Table III). It revealed that drug 
encapsulation efficiency did not attain 100%, 
this might be due to several quantity of drug 
gets dissolved in either phase. The production 
yield of all batches of fluconazole microsponges 
was ranged from 20.12% to 74.24%. The D/P 
ratio and PVA concentration were found to 
affect production yield significantly. Low 
production yield was noticed in D/P ratio of 
1:0.5 (F1), whereas, in D/P ratio 1:3 (F6) 
production yield was remarkably high i.e. 
74.24%. The results indicated that higher the 
D/P ratio, higher the production yields. At 
higher drug/polymer ratios, the rate of solvent 
diffusion from the internal to organic phase 
decreased due to the higher viscosity of the 
internal phase (Lee et al., 1999). This provided 
more time for droplet formation and improved 
the yield of microsponges besides this; the 
concentration of surfactant required to bring 
about the formation of uniform microsponges 
was found to be 0.75% w/v as illustrated in 
(Table I). The encapsulation efficiencies were in 
the range of 64.12-91.35% (Table III). The 
outcome of encapsulation efficiency reflected 
that increasing the D/P ratios (F1-F6) led to 
decrease drug loadings. 
 
Particle size 
The average particle size of microsponge 
formulations should be in the range of 5-
300µm. The Optimized batch F3 has been 
found with particle size was corresponding to 
108.16µm (Figure 3). 
 
 
Figure 3. Particle size distribution curve of 
microsponges of (F3 batch). 
 
Evaluation of fluconazole microsponge 
loaded carbopol gel 
Visual inspection 
The prepared fluconazole loaded 
microsponge gel formulations were inspected 
visually for their color, texture and appearance. 
All prepared formulations were snow white, 
viscous in nature with smooth texture and of 
good homogeneity without lumps  
 
pH measurement 
The pH values of all prepared 
formulations were found in the range of 6.5–7, 
Table IV which is supposed to be suitable to 
pass up the threat of nuisance on application to 
the skin (Neha et al., 2016). 
 
Spreadability test 
Spreadability is one of the important 
characteristics of topical formulations and               
it helps to transfer correct dosage to the           
target site and make ease of application. 
Fluconazole microsponge loaded carbopol            
934 forms a gel with spreadability ranges 
between to 7.38-11.00g cm/s. There was a 
slight decrease in spreading diameters of 
formulations of F4-F6; this variation was might 




Viscosity holds a major contribution in 
deciding the drug content and its release from 
prepared gel formulation. F3 carbopol gel 
showed approximate viscosity between 34,480-
91,350cPs. It was found that as the shear rate 
increased the viscosity of gel decreased (Harish 
et al., 2009) (Figure 4). 
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Figure 4. Viscosity versus shear rate for 





Figure 5. Dissolution profile of fluconazole 
microsponges F1–F6 and F7–F8 
 
In vitro drug release study 
The in vitro dissolution profile was done 
for fluconazole microsponge formulas (F1-
F10). From the in vitro release data it was 
noticed that the drug release was reduced from 
94.10-42.70%, this is due to D/P ratio has 
increased i.e. the amount of polymer available 
was more in each formulation. It led to 
thickening of the polymer matrix wall, thus 
lesser drug release was occurring. 94.10% of 
drug releases were found at highest drug release 
(F1) within 4Hrs, while the lowest 42.70% for 
F6 at the end of 8Hrs. It has been reported that 
by increasing the amount of PVA from batches 
F7 to F10, there was no significant change in 
the drug release pattern as compared with the 
F3 formulation. Cumulative drug release of all  
batches  F1-F6 and  F7-F10  (Figure 5).  
According to in vitro release data 
formulation code F3 was selected as an 
optimized batch. 
 
Drug release kinetics 
The drug release kinetic data are shown 
in (Table III) and (Figures 6).  From the 
graphical representation it can be understood 
that this layer is best fit in to Zero order 
kinetics which had shown a regression 
coefficient (R2) of 0.9831. The results of the in 
vitro release data of this layer were fitted to the 
Korsemeyer-Peppas equation to analyze the 
release pattern of the drug from the polymeric 
system. The value of “n” was found to be more 
than 0.89, indicating the drug release follows 
super case II transport.  
 
Effect of formulation variables 
Effect of external phase 
The concentration of PVA plays a vital 
role in the preparation of microsponges. The 
minimum concentration of emulsifier required 
for formation of uniform and stable 
microsponges was found to be 0.75% w/v of 
external phase. Almost, similar encapsulation 
efficiency was noticed formulation code F1-F6.  
When the concentration of emulsifier was 
decreased from 0.75% to 0.45% (F7) 
production yield, encapsulation efficiency and 
drug content were decreased and the formed 
microsponges were collapsed after 3 days. 
Whereas irregular microsponge was formed in 
the concentration of 0.6% w/v of emulsifier 
and table VII. When the concentration of 
emulsifier was increased to 0.9% and 1% w/v 
F9 & F10 resulted in more foam formation  
and it drastically affects production yield, 
encapsulation efficiency and drug release 
behavior. 
 
Effect of D/P ratio 
Increase in D/P ratio has been found to 
result in an increase in production yield; while 
drug content, encapsulation efficiency and 
percent drug release were found to be 
decreased table VIII. The reason behind that is 
as D/P ratio went on increasing, the polymer 
amount available for each microsponge to 
encapsulate the drug was more, thus rising 
polymer  matrix  wall thickness which led to  an 
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During stability studies, the formulation 
was found to be a snow white, homogenous, 
smooth and no changes in pH. It was also 
noticed that there were no changes in 
spreadability but slight changes in viscosity and 
drug release. Therefore, drug degradation was 
not observed. After comparative assessment of 
optimized formulation (F3) drug release 
profiles prior and after 3 months stability study, 
there were no significant differences in drug 
release profiles so, it has been concluded that 




The microsponge-based novel delivery 
system has been developed to provide once a 
day sustained release medication for topical 
delivery of Fluconazole. The method adopted 
was quasi-emulsion solvent diffusion; found to 
be simple, reproducible and rapid. Formed 
microsponges were a spherical shape, have high 
    
 




Figure 7. Drug release profile of microsponge gel during stability study 
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porosity. Different drug–polymer ratio 
reflected good particle size, drug content and 
encapsulation efficiency. Microsponge-based 
gel showed viscously and homogenizes 
preparation and in vitro drug release reflected 
highest regression value for zero order release 
model. Formulation with 1:1.5 drug–polymer 
ratio was found more efficient to give an 
extended drug release 74.20% at the end of            
8h. A gel containing microsponges prepared in 
this study was found to be promising as new-
novel delivery system offering the prolonged 
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